Explore NPLB's principles, positions and plans to make medicines affordable for all Americans, encourage innovation and ensure patients are heard.
High health plan copays are harming American families. Even with “insurance," one in four cannot afford them. If a doctor prescribes a treatment and the insurer authorizes it, the copay should be affordable. Stay up to date on the fight for insurance reforms @nplb_org
This is how the system currently works – or doesn’t work for too many people.
Scientists create a powerful new medicine in the lab. The FDA approves it. Your doctor prescribes it to treat a condition that’s been causing you pain for years. But your insurance company decides it knows better, and denies you the drug. Or allows it but only if you pay a high copay to meet your even higher annual deductible.
No Patient Left Behind, a new nonprofit, is dedicated to making medicines affordable for all Americans – while encouraging the innovation that makes those medicines possible.
Please join us in our efforts, www.nopatientleftbehind.org
Drug development is costly. Who takes the risk and funds the hope of new medicines? Investors do.
How do they know which ones will work? They often don't, but they invest in a portfolio of risks so around 1 in 10 drugs have a shot at being approved by the FDA.
While many fail, the ones that do succeed make a huge difference in the lives of patients and their loved ones. Even better, reimbursement from today’s drugs is reinvested to fund research for tomorrow’s cures.
Wondering why arbitrary price controls will harm drug innovation?
Watch this video and it will make sense.